Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.

Sarcoidosis, vasculitis, and diffuse lung diseases …, 2015 - europepmc.org
Background SSc-ILD and IPF demonstrate significant morbidity and mortality. Predicting
disease progression is challenging in both diseases. Objectives We sought a serum …
被引用次数：62 相关文章

Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis

B Kennedy, P Branagan, F Moloney… - … , and diffuse lung …, 2015 - pubmed.ncbi.nlm.nih.gov
Background SSc-ILD and IPF demonstrate significant morbidity and mortality. Predicting
disease progression is challenging in both diseases. Objectives We sought a serum …